Screening Phase for Multiple Myeloma

University Of Chicago Medicine Comprehensive Cancer Center, Chicago, IL
Multiple MyelomaScreening Phase - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will also compare the accuracy of liquid biopsies (blood tests) to standard bone marrow biopsies in detecting MRD.

Eligible Conditions
  • Multiple Myeloma

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
AB-1015
1
ARV-471 in combination with Ribociclib
1
OPL-0401 Dose 1

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: 3 years

3 years
Determine the MRD conversion rate
Determine the difference in MRD detection by NGS
Median Progression Free Survival rate
Median overall survival rate
NGS-based Minimal Residual Disease testing determined by the ClonoSeq assay

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
AB-1015
2
ARV-471 in combination with Ribociclib
2
OPL-0401 Dose 1

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

MRD2STOP ARM
1 of 1

Experimental Treatment

56 Total Participants · 1 Treatment Group

Primary Treatment: Screening Phase · No Placebo Group · N/A

MRD2STOP ARMExperimental Group · 2 Interventions: Screening Phase, Discontinuation Phase · Intervention Types: Other, Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 years

Who is running the clinical trial?

University of ChicagoLead Sponsor
947 Previous Clinical Trials
759,917 Total Patients Enrolled
15 Trials studying Multiple Myeloma
1,814 Patients Enrolled for Multiple Myeloma
Andrzej Jakubowiak, MDPrincipal InvestigatorUniversity of Chicago
2 Previous Clinical Trials
297 Total Patients Enrolled
2 Trials studying Multiple Myeloma
297 Patients Enrolled for Multiple Myeloma

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have had or currently have another type of cancer, but it will not affect the evaluation of the treatment being studied.
References

Frequently Asked Questions

Are there still openings for participants in this clinical research?

"Affirmative. According to the information on clinicaltrials.gov, this trial is currently recruiting patients who it first posted about in October of 2019 and updated most recently around January 8th 2021. 56 participants are needed from 1 study site." - Anonymous Online Contributor

Unverified Answer

What is the maximum enrollment capacity for this clinical trial?

"Affirmative. Clinicaltrials.gov data states that this trial, which was launched on October 30th 2019, is actively enlisting people into the research project. The clinical study requires 56 participants from one medical facility to be recruited." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top